Studies of meningococcal evolution and genetic population structure, including the long-term stability of non-random associations between variants of surface proteins, are essential for vaccine development. We analyzed the sequence variability of factor H-binding protein (fHbp), Neisserial Heparin-Binding Antigen (NHBA) and Neisseria adhesin A (NadA), three major antigens in the multicomponent meningococcal serogroup B vaccine 4CMenB. A panel of invasive isolates collected in the Netherlands over a period of 50 years was used. To our knowledge, this strain collection covers the longest time period of any collection available worldwide. Long-term persistence of several antigen sub/variants and of non-overlapping antigen sub/variant combinati...
Meningococcal disease, caused by the bacterium Neisseria meningitidis, is an important cause of morb...
The prevention of meningococcal disease may be improved by recombinant vaccines such as 4CMenB and r...
There is currently no comprehensive meningococcal vaccine, due to difficulties in immunizing against...
Studies of meningococcal evolution and genetic population structure, including the long-term stabili...
Neisseria meningitidis is a major cause of septicaemia and meningitis worldwide. Most disease in Eur...
Studies of meningococcal genetic population structure, including the potential associations between ...
<div><p><em>Neisseria meningitidis</em> is a major cause of septicaemia and meningitis worldwide. Mo...
International audienceBackground. Recombinant forms of Neisseria meningitidis human factor H binding...
ABSTRACT Neisseria meningitidis, one of the major causes of bacterial meningitis and sepsis, is a me...
ABSTRACT Neisseria meningitidis, one of the major causes of bacterial meningitis and sepsis, is a me...
Most studies of bacterial pathogen populations have been based on isolates collected from individual...
International audienceThe prevention of meningococcal disease may be improved by recombinant vaccine...
In September 2015, 4CMenB meningococcal vaccine was introduced into the United Kingdom infant immuni...
BackgroundNeisseria meningitidis (meningococcus) is the causative agent of invasive meningococcal di...
The prevention of meningococcal disease may be improved by recombinant vaccines such as 4CMenB and r...
Meningococcal disease, caused by the bacterium Neisseria meningitidis, is an important cause of morb...
The prevention of meningococcal disease may be improved by recombinant vaccines such as 4CMenB and r...
There is currently no comprehensive meningococcal vaccine, due to difficulties in immunizing against...
Studies of meningococcal evolution and genetic population structure, including the long-term stabili...
Neisseria meningitidis is a major cause of septicaemia and meningitis worldwide. Most disease in Eur...
Studies of meningococcal genetic population structure, including the potential associations between ...
<div><p><em>Neisseria meningitidis</em> is a major cause of septicaemia and meningitis worldwide. Mo...
International audienceBackground. Recombinant forms of Neisseria meningitidis human factor H binding...
ABSTRACT Neisseria meningitidis, one of the major causes of bacterial meningitis and sepsis, is a me...
ABSTRACT Neisseria meningitidis, one of the major causes of bacterial meningitis and sepsis, is a me...
Most studies of bacterial pathogen populations have been based on isolates collected from individual...
International audienceThe prevention of meningococcal disease may be improved by recombinant vaccine...
In September 2015, 4CMenB meningococcal vaccine was introduced into the United Kingdom infant immuni...
BackgroundNeisseria meningitidis (meningococcus) is the causative agent of invasive meningococcal di...
The prevention of meningococcal disease may be improved by recombinant vaccines such as 4CMenB and r...
Meningococcal disease, caused by the bacterium Neisseria meningitidis, is an important cause of morb...
The prevention of meningococcal disease may be improved by recombinant vaccines such as 4CMenB and r...
There is currently no comprehensive meningococcal vaccine, due to difficulties in immunizing against...